Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Fierce biotech
View:
Comment by LOOPA441 on Apr 19, 2022 4:21pm
Neither party has shared the financial terms of the deal. Bioasis flagged up financial difficulties at the start of the year, warning investors of “a material uncertainty that may raise significant doubt about [its] ability to continue as a going concern.” At that time, Bioasis said it had enough cash to fund its operation “through approximately May 2022.”
Comment by KayakerBC on Apr 19, 2022 6:57pm
LOOPA441... That looks likes a standard boilerplate warning to me. He's referring to this in the Jan 2022 MD&A... "....Readers should note that the Company currently has an accumulated deficit of $40,087,203 and working capital of $113,630, and for the nine months ended November 30, 2021 had a net loss of $2,393,328 and cash flow used in operating activities of $2,954,868. These ...more  
Comment by chrispi on Apr 20, 2022 9:44am
As KayakerBC already mentioned, this is standard operating boilerplate language when a company has less than one year of operating funds on the books. I've seen it a million times in many small companies. Anyways, astute readers (all those who aren't trolls ;) on this board will know that they still have a $7m USD line of credit with Lind that they can withdraw from at their choosing of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities